chr3-43081068-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_032806.6(POMGNT2):c.364G>A(p.Val122Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000689 in 1,614,194 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V122L) has been classified as Uncertain significance.
Frequency
Consequence
NM_032806.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
POMGNT2 | NM_032806.6 | c.364G>A | p.Val122Met | missense_variant | 2/2 | ENST00000344697.3 | |
POMGNT2 | XM_005265515.4 | c.364G>A | p.Val122Met | missense_variant | 3/3 | ||
POMGNT2 | XM_011534163.3 | c.364G>A | p.Val122Met | missense_variant | 3/3 | ||
POMGNT2 | XM_017007353.2 | c.364G>A | p.Val122Met | missense_variant | 4/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
POMGNT2 | ENST00000344697.3 | c.364G>A | p.Val122Met | missense_variant | 2/2 | 1 | NM_032806.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00320 AC: 487AN: 152196Hom.: 4 Cov.: 33
GnomAD3 exomes AF: 0.000986 AC: 248AN: 251420Hom.: 3 AF XY: 0.000839 AC XY: 114AN XY: 135890
GnomAD4 exome AF: 0.000428 AC: 625AN: 1461880Hom.: 5 Cov.: 37 AF XY: 0.000393 AC XY: 286AN XY: 727242
GnomAD4 genome AF: 0.00320 AC: 487AN: 152314Hom.: 4 Cov.: 33 AF XY: 0.00309 AC XY: 230AN XY: 74476
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Mar 10, 2017 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 31, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 09, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 21, 2017 | - - |
POMGNT2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 19, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at